Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.
about
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsAlternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesAre cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewPharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in MuscleCannabinoids, eating behaviour, and energy homeostasis.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypesThe plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodentsMarijuana and body weightBeyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆(9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout miceModulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.Association Between Use of Cannabis in Adolescence and Weight Change into MidlifeThe cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesityLong-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice.Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetiteCannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans.Molecular Pharmacology of Phytocannabinoids.The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.A quick look at obesity; the enemy withinCannabinol and cannabidiol exert opposing effects on rat feeding patterns.Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsiv
P2860
Q24606148-E3179C2D-1ED0-4A24-9F24-A1CC6D2FA21EQ26824588-710510B6-EA2F-4BCB-AB12-498C8B7D667FQ27005619-918E5405-77C8-4725-9AE8-B737757114A7Q28551556-3458B66B-253C-4ADA-85D7-D271FF2A40FEQ30357350-5B2EEEB8-04A1-44EF-90CF-1EA348A236B2Q33908169-45C672FB-39B7-4E43-AB3A-C9EFEB651D1FQ34006919-07328E2C-1CB2-49CE-9415-FC7E7FF215D2Q34098266-2DB061BF-8C49-408F-8C65-07E790EC76A2Q34140803-6A730594-6BEF-496E-956A-F95A55A8F460Q34377446-2806BBD7-AC1B-4A69-BC2A-E7FEFA37AFCAQ34676610-7ED7F197-F69D-40ED-B99C-8D3E1A08DBAEQ34766609-1E3C9D9D-0283-4270-9432-93F7FDFF5647Q35643909-70CBB4BC-FFD2-4C0F-937D-DB17969CA4BCQ36070972-06C717F1-C636-4EDB-B095-A71A1599E8E1Q36147328-7FB8B0D6-7CE5-4EBD-ACA3-A1CA2A5BB7AAQ36176486-086BF2E8-CB80-4589-80A4-0993F8694CE9Q36242504-44ED48CD-5BCE-4A7C-8549-00719B4A4A3AQ36900366-BA86EED9-945F-43D3-B74B-84F2A236D159Q37453590-D8C4A6A1-DE89-4E10-ABC6-ED25843F82F3Q37717854-F7AE2CA8-C0F5-4AA2-A321-50844CA3AAF5Q37826693-0EA2567F-A73B-407B-AC38-1C11EF0B5FD0Q37960078-DF30FA29-3C53-432D-B943-05130F8936F1Q38598493-63A92A4E-DC1E-42BC-B884-43DFA755631BQ39102188-C63C976C-5350-4344-AA9D-35B89AA1CFA9Q39283731-1A204925-2602-434E-AD6F-CF10928FA916Q39489160-CABECB7E-DF02-4F13-9946-9A549A0E3A64Q39623454-172C9DD3-5C65-40E7-9AFA-366E3CB5BE4CQ41152430-5AB42D0B-FB17-4BC4-9F44-FA53F5861FABQ41907106-8D2DE4A1-8CDE-4403-A97D-59EE2BEFB8CDQ45288843-0A0F8079-8A84-4890-A523-EE549564D9BAQ52147449-2F242996-E5F0-41FA-9386-3A8A144FE4D9Q56768080-EA70C554-D12D-4C89-92BD-54F941B328E5
P2860
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Synthetic and plant-derived ca ...... in fasted and non-fasted mice.
@en
type
label
Synthetic and plant-derived ca ...... in fasted and non-fasted mice.
@en
prefLabel
Synthetic and plant-derived ca ...... in fasted and non-fasted mice.
@en
P2093
P2860
P921
P1476
Synthetic and plant-derived ca ...... in fasted and non-fasted mice.
@en
P2093
Bettina Platt
Gernot Riedel
Lianne Robinson
Paola Fadda
Roger G Pertwee
Susan McKillop-Smith
P2860
P304
P356
10.1111/J.1476-5381.2008.00107.X
P407
P577
2009-04-01T00:00:00Z